The Limited Times

Now you can see non-English news...

Anti-Covid vaccines: Macron anticipates "250 million doses of vaccine" produced in France for 2021

2021-04-09T10:56:05.506Z


"At the end of April, beginning of May, we will be at full speed and we will still increase the pace during the summer, 24 hours a day, seven days a week," assured


"We will produce on our soil in 2021, 250 million doses of vaccine for France and Europe", projected this Friday the President of the Republic, traveling in the company Delpharm, in the Eur-et -Loire, which has been bottling Pfizer / BioNTech's vaccine against Covid-19 since Wednesday, a first on French soil.

According to him, "the group will also have 20 million aid in Tours

(Editor's note: on the other Delpharm site)

for pre-filled syringes, which will make it possible to inject the messenger RNA vaccine even more easily".

"Four sites in France are going to produce, also announced Emmanuel Macron," At the end of April, at the beginning of May, we will be at full speed and we will still increase the pace during the summer, 24 hours a day, seven days a week.

"It is really a collective and national war effort", he insisted during a quick press briefing.

Regarding the vaccine on which the Sanofi laboratory is working, the president specifies that he "is in the process of progressing", with "another technique, the recombinant protein".

He also mentioned the European vaccine project Valneva, "which will allow us to complete our portfolio of European vaccines".

AstraZeneca vaccine is "recommended"

Regarding the vaccine from the laboratory AstraZeneca, linked to serious adverse effects, Emmanuel Macron hammered it: the latter is "recommended".

"We are in complete transparency, whenever problems arise with a particular vaccine, they are made public and are the subject of a scientifically independent study," he said, referring to cases of thrombosis , "In particular in younger, more feminine subjects".

"Our health authorities are looking at the balance between cost and benefit", also explained the president, who recalls that "the French health authorities will have to decide in the coming days".

"The analysis carried out by the European authority was to say that (...) this benefit / risk pair is completely positive for people over 60 years old".

He continues: "The choice we are betting on today (...) is that for all people over 55, with a risk factor - if they catch the virus, they have a very good chance to develop serious forms, to go to intensive care or even to die - the vaccine is recommended ”.

Resumption of classes with "a very proactive testing policy"

Emmanuel Macron also returned to the vaccination of teachers.

"Our vaccination strategy follows the recommendations of health authorities and specialists," he recalls, detailing a "strategy that starts with the oldest and goes down by age group".

"From a public health point of view, it would make no sense to vaccinate a teacher of 30 in priority over his parents of 70 years", he argued, dropping the term "sanitary misconception".

As his Minister of Health Olivier Véran had already outlined, the president announced the start "in the coming weeks" of a "priority vaccination of teachers, AESH (Support for students with disabilities) and staff in contact with people with disabilities ”, in particular“ children or adolescents who cannot wear a mask ”.

"From the moment we open vaccination to people under 55, we will have a policy of prioritizing vaccination, including teachers," he added.

Morning essentials newsletter

A tour of the news to start the day

Subscribe to the newsletterAll newsletters

Regarding the start of the school year, scheduled for the beginning of May, the Head of State also mentioned a "same protocol for the resumption of classes", with a "very proactive testing policy", in particular self-tests. .

Source: leparis

All life articles on 2021-04-09

You may like

Trends 24h

Life/Entertain 2024-03-28T17:17:20.523Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.